# Timing-controlled concept for extubation in brachycephalic dogs: α2–bridged on-demand extubation

**Authors:** Shotaro Nagahama

PMC · DOI: 10.3389/fvets.2026.1762485 · 2026-02-24

## TL;DR

This paper proposes a new timing-controlled extubation method for brachycephalic dogs to reduce respiratory complications during recovery from anesthesia.

## Contribution

The novel A2-ODE concept decouples volatile washout from extubation timing using α2-agonist sedation and atipamezole.

## Key findings

- A2-ODE aims to avoid extubation during a vulnerable emergence phase by using α2-agonist sedation.
- The protocol allows clinician-controlled timing of awakening and extubation in brachycephalic dogs.
- The concept is presented as a hypothesis-generating framework for future clinical studies.

## Abstract

Brachycephalic dogs are overrepresented among peri and post-anesthetic respiratory complications, and many serious adverse events in small animals cluster around extubation and early recovery. A recurring clinical problem is a mismatch between apparent behavioral emergence and incomplete recovery of upper-airway stability, such that extubation may occur while residual anesthetic effect still depresses pharyngeal dilator activity and protective reflexes. Brachycephalic dogs have anatomically constrained, load-sensitive upper airways, making emergence a phase in which behavioral arousal may precede full recovery of airway stability. We propose a timing-controlled concept for extubation in brachycephalic dogs—α2–Bridged on-Demand Extubation (A2-ODE)—that decouples volatile washout from the timing of awakening and extubation. In A2-ODE, the vaporizer is turned off and washout is completed, as far as practicable, while the airway remains secured under a low to moderate-dose α2-agonist sedative bridge; awakening is then intentionally triggered by atipamezole immediately before planned extubation. The sequence is designed to avoid extubation within a volatile-associated vulnerable emergence range, stabilize the emergence phenotype, and provide clinician-controlled timing of wakefulness and extubation. We outline a stepwise protocol, discuss key prerequisites, limitations and hemodynamic considerations, and propose testable predictions for prospective clinical and physiologic studies in brachycephalic patients. This is a conceptual, hypothesis-generating article; A2-ODE is intended as a framework for future clinical studies rather than a validated protocol for routine use.

## Linked entities

- **Chemicals:** atipamezole (PubChem CID 71310)

## Full-text entities

- **Diseases:** respiratory complications (MESH:D012140)
- **Chemicals:** atipamezole (MESH:C050701)
- **Species:** Homo sapiens (human, species) [taxon 9606], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12974264/full.md

---
Source: https://tomesphere.com/paper/PMC12974264